Clinical Challenges in Migraine: The Role of Emerging Therapies in New Treatment Paradigms

Please Log In or Register to continue.

Release Date: August 01, 2017
Expiration Date: August 01, 2018

Expected time to complete this activity as designed: 60 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

Join the discussion with our faculty as they present the most up-to-date information being reported in clinical trials for the new calcitonin gene-related peptide (CGRP) inhibitors. Whether you're learning this information for the first time or you want to hear more of the newest information about how CGRP inhibitors may change your practice, you'll leave this session with a new insight into how what's happening in clinical trials today will impact your practice in the near future. This enduring program was streamed live from Headache Update 2017.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, nurses, and other health care professionals who have an interest in migraine and other headache disorders.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Outline current challenges and barriers to the effective prevention of migraine
  • Describe the role of calcitonin gene-related peptide
  • Summarize data focusing on new and emerging preventive treatments for episodic and chronic migraine


The Migraine Evolution Process and Treatment Today – Merle L. Diamond, MD

From Bench to Practice: Expert Perspectives on Emerging Strategies and Novel Agents for Migraine Prevention ‒The Science of Migraine – Stewart J. Tepper, MD

Instructions for Participation and Credit

This activity is eligible for credit through August 1, 2018. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME and CNE may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biographies

Merle L. Diamond, MD
President, Managing Director
Diamond Headache Clinic
Chicago, Illinois

Dr. Merle L. Diamond is President and Managing Director of the Diamond Headache Clinic in Chicago, Illinois. She is also an Attending Physician in Internal Medicine at Saint Joseph Hospital. In addition, she serves as Clinical Assistant Professor in the Department of Medicine of Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, Illinois.

Dr. Diamond graduated with high honors from the University of Michigan, Ann Arbor, Michigan, and received her medical education from Northwestern University Feinberg School of Medicine, Chicago. She completed residencies in emergency medicine/internal medicine at McGaw Medical Center of Northwestern University, Chicago, Illinois. Dr. Diamond is board certified in internal medicine, has been trained and practiced in emergency medicine, and has been elected as a fellow of the American College of Emergency Physicians. She is a recipient of the Subspecialty Certification for Headache Medicine from the United Council for Neurologic Subspecialties.

Dr. Diamond joined the staff of the Diamond Headache Clinic in 1989 after serving as an attending physician and clinical instructor at Northwestern University Hospital, Chicago, and as an attending physician at Evanston and St. Francis Hospitals, both in Evanston, Illinois. She has contributed numerous articles to the medical literature, and has lectured extensively on various headache subjects, and in particular, the treatment of headache in the Emergency Department, women and headaches, and children with headaches. Dr. Diamond is co-editor of Diamond and Dalessio’s The Practicing Physician’s Approach to Headache, 6th Edition.

Stewart J. Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Dr. Stewart Tepper received his medical degree from Cornell University Medical College. He completed his internal medicine internship at Boston University Hospital, his PGY-2 internal medicine residency at University of Washington School of Medicine, and his neurology residency at Harvard. Dr. Tepper is Professor of Neurology at the Geisel School of Medicine at Dartmouth (Dartmouth Medical School), Hanover, New Hampshire, and Director of the Dartmouth Headache Center, Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Dr. Tepper is board-certified in headache medicine. He is co-director of the Scottsdale Headache Symposium course of the American Headache Society, and was also director of the Headache Therapy course for the American Academy of Neurology. He is editor-in-chief of the journal Headache Currents, and associate editor for Headache. Dr. Tepper has published more than 320 peer-reviewed manuscripts, editorials, and books, including The Cleveland Clinic Manual of Headache Therapy, Second Edition.


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-17-162-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 17-162-062


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosures

Dr. Merle Diamond has received honoraria related to speakers’ bureau activities from Allergan, Inc., Avanir Pharmaceuticals, Inc., Depomed, Inc., PERNIX Therapeutics, and Teva Pharmaceutical Industries Ltd.

Dr. Stewart Tepper has received honoraria as a consultant from Acorda, Alder BioPharmaceuticals Inc., Allergan, Inc., Amgen Inc., ATI, Avanir Pharmaceuticals, Inc., BioVision Inc., electroCore, LLC, Eli Lilly and Company, eNeura Inc., Kimberly-Clark, PERNIX Therapeutics, Pfizer Inc., TEVA Pharmaceutical LTD, and Zosano Pharma Corporation; and honoraria related to formal advisory activities from Alder, Allergan, Amgen, ATI, Avanir, Dr. Reddy’s Laboratories Ltd., Kimberly-Clark, Scion NeuroStim, TEVA, and Pfizer Inc. Dr. Tepper has also received royalties or licensing fees from Springer and the University of Mississippi Press. He has disclosed a financial relationship with the American Headache Society, Dartmouth-Hitchcock Medical Center, and has stock options with ATI.

Planning Committee Disclosures

The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Teva Pharmaceuticals

©2017 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

Please Log In or Register to continue.